ArticleFood chemistry: X2026
Ultrasound-assisted maillard reaction: a novel strategy for debittering, flavor enhancement, and antioxidant activity improvement of walnut peptides.
Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Walnut peptides (WP) show excellent antioxidant, anti-inflammatory, antihypertensive, and immunomodulatory activities, making them promising for functional foods and nutritional supplements. However, hydrophobic amino acids formed during enzymatic hydrolysis cause severe bitterness, limiting their application. This study investigated the debittering effect of ultrasound-assisted Maillard reaction (US-MR) on WP by applying ultrasonic pretreatment at different amplitudes followed by Maillard reaction. Results indicated that US-MR promoted WP-glucose conjugation, increased browning intensity and free amino acid content, and enhanced antioxidant activity. Treatment at 30% amplitude achieved the best performance, with the highest fluorescent compound content, the largest reduction in bitter amino acids, and abundant volatile flavors such as aldehydes, ketones, furans, and pyrazines. Sensory evaluation confirmed improved aroma, umami, and texture with significantly reduced bitterness. US-MR thus provides an effective strategy to mitigate WP bitterness and facilitate the development of high-value walnut peptide products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.